ALERT: Rosen Law Firm Reminds Geron Corporation Investors of Important Class
Action Deadline -- GERN
NEW YORK, April 3, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. reminds
all purchasers of the common stock of Geron Corporation (Nasdaq:GERN) from
June 16, 2013 through March 11, 2014, of the important May 13, 2014 lead
plaintiff deadline in the class action.
To join the GERN class action, go to the website at http://rosenlegal.com or
call Phillip Kim, Esq. or Jonathan Horne, Esq. toll-free at 866-767-3653 or
email firstname.lastname@example.org or email@example.com for information on the
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY
ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT.YOU MAY
RETAIN COUNSEL OF YOUR CHOICE.
GERN is a clinical stage company with only one drug in development –
imetelstat – which is in Phase 2 trials. The Complaint alleges that between
June 16, 2013, and March 11, 2014, Geron omitted to disclose material facts
showing imetelstat's poor prospects, including that (1) persistent low-grade
liver function test (LFT) abnormalities had been observed in the Phase 2 study
of imetelstat in essential thrombocythemia (ET) or polycythemia vera (PV)
patients and (2) there was a potential risk of chronic liver injury following
long-term exposure to imetelstat.
On March 12, 2014, GERN announced that the Food and Drug Administration had
verbally informed it that a clinical hold would be placed on imetelstat
clinical trials, citing the LFT abnormalities and the potential risk of
chronic liver injury. The FDA is also concerned that both may be irreversible.
That day, GERN's stock price fell $2.71, or 62%, on heavy volume, damaging
A class action lawsuit has already been filed.If you wish to serve as lead
plaintiff, you must move the Court no later than May 13, 2014.If you wish to
join the litigation or to discuss your rights or interests regarding this
class action, please contact, Phillip Kim, Esq. or Jonathan Horne, Esq. of The
Rosen Law Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org
The Rosen Law Firm focuses on prosecuting securities class action litigation
and actions involving financial fraud.The Rosen Law Firm represents investors
throughout the globe concentrating its practice in securities class actions.
CONTACT: Laurence Rosen, Esq.
Phillip Kim, Esq.
Jonathan Horne, Esq.
The Rosen Law Firm P.A.
275 Madison Avenue 34th Floor
New York, New York 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
Press spacebar to pause and continue. Press esc to stop.